Galaxy Diagnostics

Galaxy Diagnostics We offer advanced diagnostic test solutions that go beyond the limits of detection for low- abundance pathogens.

We test for a range of flea and tick-borne pathogens, specializing in Bartonella, Borrelia, and Babesia. Galaxy Diagnostics is building awareness about Bartonella as a potential cause of disease in animals and humans. The purpose of this page is to share the latest Bartonella research and other developments related to this important area of emerging infectious disease. The CDC reports that over 60% of emerging infectious diseases are zoonotic (from animals). Vectors (insects and arthropods) play an important role in transmission of zoonotic diseases. The One World, One Health Initiative was launched recently to focus attention on the intersections between human health, animal health, and the health of the environment. It is critical that medical practitioners and public health workers become aware of the risk factors and clinical symptoms associated with all zoonotic infections, including the ones linked to chronic disorders.

04/09/2026

Standard Lyme testing doesn’t always capture the full picture.

Here’s what can get overlooked:

Only using indirect testing: Many standard tests measure the body’s immune response – not the pathogen itself.

Not testing for co-infections: Ticks often carry more than one pathogen, but testing doesn’t always reflect that complexity.

Testing for a limited number of species: There isn’t just one type of Borrelia, Bartonella, or Babesia. For example, over 20 Bartonella species are known to infect humans, and yet most tests only check for a few.

At Galaxy Diagnostics, we take a different approach, focusing on direct detection and comprehensive testing designed to better reflect the complexity of tick-borne disease.

Better testing leads to better answers.

This is what we’re reading right now 👇Staying current matters – because the landscape is changing quickly.Swipe to check...
04/08/2026

This is what we’re reading right now 👇

Staying current matters – because the landscape is changing quickly.

Swipe to check out a few studies that caught our attention.

Where do you see the biggest gaps in tick-borne research today? Let us know in the comments!

Did you know a blood draw isn’t the only way to test for Lyme?It’s true – approaches to Lyme testing are evolving beyond...
04/07/2026

Did you know a blood draw isn’t the only way to test for Lyme?

It’s true – approaches to Lyme testing are evolving beyond blood alone.

Currently, most standard Lyme tests rely on antibody detection in the bloodstream. But that doesn’t always reflect how the pathogen behaves.

When we rely on antibody testing alone, we’re measuring the body’s immune response – not the pathogen itself.

And that response can vary. Especially if the infection is early, or if the immune system isn’t mounting a strong signal.

That’s why we utilize newer approaches that use direct detection, including identifying proteins from the pathogen itself using alternative sample types like urine.

In published research, Nanotrap® technology detected Borrelia antigen in all 24 patients with a Lyme rash prior to treatment, while none of the control samples tested positive.

Advancing diagnostics starts with understanding the biology.

Swipe to explore how Lyme detection is evolving.

For clinicians managing complex, chronic cases, clarity matters more than anything.That’s why many providers turn to adv...
04/02/2026

For clinicians managing complex, chronic cases, clarity matters more than anything.

That’s why many providers turn to advanced diagnostics when they need more than just a result – they need actionable, objective data.

We’re proud to support clinicians like Dr. Chris Turnpaugh of who prioritize deeper investigation and evidence-based care.

Because better answers lead to better decisions.

Link in bio to learn more about Galaxy’s testing methodology and how we support comprehensive tick-borne diagnostics.

Babesia is no longer rare.U.S. cases have more than doubled over the past decade, and diagnoses are being reported in mo...
03/31/2026

Babesia is no longer rare.

U.S. cases have more than doubled over the past decade, and diagnoses are being reported in more states than ever before.

Like malaria, Babesia is an intraerythrocytic parasite, meaning it invades red blood cells.

Red blood cells are responsible for delivering oxygen to every tissue in the body. When those cells are infected, oxygen transport is compromised. The result is systemic.

Reduced oxygen delivery can trigger fatigue, shortness of breath or “air hunger,” night sweats, headaches, cognitive dysfunction, and in more severe cases, hemolytic anemia and organ stress.

When the cells that fuel the entire body are disrupted, the effects ripple outward.

Learn more about Galaxy’s Babesia testing options and how we support comprehensive tick-borne diagnostics: https://www.galaxydx.com/about-us/

03/30/2026

In a recent conversation on the podcast, Jennifer C. Miller, PhD, reflected on something many clinicians have long recognized: tick-borne disease is rarely about a single pathogen.

Decades ago, CDC tick surveillance studies revealed something – the average tick often carries a lot more than Lyme disease. Dozens of potential microbes, some well-studied and others far less understood.

When exposure involves more than one organism, clinical presentation becomes more difficult.

Complex infections require complex thinking.

Understanding the full microbial landscape inside the tick is just part of understanding what may be happening inside the patient.

Watch the full interview to explore the evolving science behind co-infections, and why comprehensive detection is so important.

03/27/2026

We need to start examining the infectious causes behind neurological and cognitive changes.

For Galaxy Diagnostics CEO Nicole, this understanding came through personal experience.

About a decade ago, her husband’s personality began to change. Therapy didn’t help, and lab after lab came back normal.

Finally, doctors diagnosed him with early-onset Alzheimer’s.

It wasn’t until nearly two years later, when specialty testing revealed he was actually positive for multiple tick-borne infections, including Lyme, Bartonella, and Babesia.

By the time the diagnosis came, his neurological decline was severe. Nicole’s husband passed away in 2022.

Experiences like this are why Galaxy exists.

Our mission is to help equip providers with better tools to detect complex tick-borne infections, so patients and families have a better chance of finding answers sooner.

Babesiosis may be far more common than the initial numbers suggest.Survey data from indicates cases could be undercount...
03/26/2026

Babesiosis may be far more common than the initial numbers suggest.

Survey data from indicates cases could be undercounted by as much as 25× – with an estimated 46,000 U.S. cases annually, compared to 1,834 reported by the CDC.
Improving both clinical awareness and improving diagnostic sensitivity is essential to understanding the true scope of disease burden – particularly for stealth pathogens like Babesia.

We’re committed to helping move that progress forward.

Lyme disease doesn’t always occur in isolation.Ticks frequently carry more than one pathogen. In fact, in one study, nea...
03/24/2026

Lyme disease doesn’t always occur in isolation.

Ticks frequently carry more than one pathogen. In fact, in one study, nearly 45% of infected Ixodes ticks harbored multiple organisms.

And yet, testing practices don’t always reflect that reality.

When co-infections aren’t considered, they’re less likely to be identified. And when they’re missed, patients are left dealing with prolonged symptoms while providers must navigate with incomplete data.

Co-infections require clinical awareness, and advanced diagnostic strategies designed to detect them.

Swipe to explore what that means – and why it matters.

03/23/2026

Not all tick and vector-borne disease testing uses the same approach. Here are 3 reasons infections are so often missed – and how we’re changing the standard.

1️⃣ Timing of testing: Tick-borne infections don’t stay at consistent levels in the bloodstream. Early in infection, antibodies may not yet be detectable. Later, microbes may circulate at very low or intermittent levels, which can result in a negative test even when infection is present.

2️⃣ Using antibody-based testing alone: Most tests measure the body’s immune response rather than the pathogen itself. Antibody production can vary, especially after prior treatment. As a result, antibody-only testing doesn’t always reflect active infection.
3️⃣ Assay sensitivity and methodology: Differences in sample preparation, target selection, and quality controls influence whether small amounts of microbial DNA are identified. When sensitivity is limited, these low-level infections can go undetected.

At Galaxy Diagnostics, we approach tick-borne testing differently.

Instead of relying solely on immune response, we focus on direct molecular detection – identifying microbial DNA using advanced PCR-based methodologies designed for high sensitivity.

Because when providers have better tools, patients get better answers.

03/20/2026

The blood–brain barrier is protective – but it’s not impenetrable.

In our recent educational webinar, Jennifer C. Miller, PhD, of Galaxy Diagnostics, explained how Bartonella may breach this barrier through multiple mechanisms.

And once inside the central nervous system, the effects can be wide-reaching.

This might include symptoms from neuropathic pain and cognitive dysfunction to mood changes, encephalopathy, and, in rare cases, more severe complications.

As Dr. Miller emphasized, improving diagnostic accuracy starts with understanding what these organisms are biologically capable of.

Link in bio to watch the full webinar to explore the science behind Bartonella and the evolving approach to advanced tick-borne detection.

Lyme and tick-borne disease awareness is growing – and we’re absolutely thrilled to see it happening. It validates what ...
03/20/2026

Lyme and tick-borne disease awareness is growing – and we’re absolutely thrilled to see it happening.

It validates what both clinicians and patients have been seeing for years.

But awareness is only the first step.

What really makes change is action – stronger science, better diagnostics, and scalable innovation.

We’re proud to be part of that next phase, including bringing Dr. Brandon Jutras’s innovative peptidoglycan antigen detection technology into our diagnostic pipeline through our partnership with .tech

Momentum is building. Now let’s translate it into impact 💚

Address

6 Davis Drive
Durham, NC
27709

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+19193139672

Website

Alerts

Be the first to know and let us send you an email when Galaxy Diagnostics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Galaxy Diagnostics:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category